FRIDAY, October 16, 2009 Sala Verde – 4.45-7.00 pm
Symposium
HDAC INHIBITORS: EMERGING DRUGS WITH PLEIOTYPIC THERAPEUTIC POTENTIAL
Chairpersons: Chiarugi A. (Florence), Mascagni P. (Milan)

 

 
 
TARGETING HISTONE DEACETYLASES: VORINOSTAT AND NOVEL CLASSES OF HDACI
Steinkühler C. (Roma)

HDACS AND APOPTOSIS: IS HDAC4 A GOOD TARGET?”
Brancolini C. (Udine)

HDAC INHIBITORS AS NOVEL ANTI-INFLAMMATORY AGENTS
Dinarello C. A. (Denver)

EPIGENETIC BASIS OF MUSCLE REGENERATION IN MUSCULAR DYSTROPHY
Puri P. (Roma)

HISTONE DEACETYLASE INHIBITORS IN CANCER: GIVINOSTAT, A CASE STUDY
Fossati G. (Milan)

REGULATION OF SELF-RENEWAL IN CANCER STEM CELLS
Pelicci P. G. (Milan)